Literature DB >> 11903058

Nuclear receptor corepressor-dependent repression of peroxisome-proliferator-activated receptor delta-mediated transactivation.

Anne-M Krogsdam1, Curt A F Nielsen, Søren Neve, Dorte Holst, Torben Helledie, Bo Thomsen, Christian Bendixen, Susanne Mandrup, Karsten Kristiansen.   

Abstract

The nuclear receptor corepressor (NCoR) was isolated as a peroxisome-proliferator-activated receptor (PPAR) delta interacting protein using the yeast two-hybrid system. NCoR interacted strongly with the ligand-binding domain of PPAR delta, whereas interactions with the ligand-binding domains of PPAR gamma and PPAR alpha were significantly weaker. PPAR-NCoR interactions were antagonized by ligands in the two-hybrid system, but were ligand-insensitive in in vitro pull-down assays. Interaction between PPAR delta and NCoR was unaffected by coexpression of retinoid X receptor (RXR) alpha. The PPAR delta-RXR alpha heterodimer bound to an acyl-CoA oxidase (ACO)-type peroxisome-proliferator response element recruited a glutathione S-transferase-NCoR fusion protein in a ligand-independent manner. Contrasting with most other nuclear receptors, PPAR delta was found to interact equally well with interaction domains I and II of NCoR. In transient transfection experiments, NCoR and the related silencing mediator for retinoid and thyroid hormone receptor (SMRT) were shown to exert a marked dose-dependent repression of ligand-induced PPAR delta-mediated transactivation; in addition, transactivation induced by the cAMP-elevating agent forskolin was efficiently reduced to basal levels by NCoR as well as SMRT coexpression. Our results suggest that the transactivation potential of liganded PPAR delta can be fine-tuned by interaction with NCoR and SMRT in a manner determined by the expression levels of corepressors and coactivators.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11903058      PMCID: PMC1222462          DOI: 10.1042/0264-6021:3630157

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  51 in total

1.  The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors.

Authors:  X Hu; M A Lazar
Journal:  Nature       Date:  1999-11-04       Impact factor: 49.962

Review 2.  The coregulator exchange in transcriptional functions of nuclear receptors.

Authors:  C K Glass; M G Rosenfeld
Journal:  Genes Dev       Date:  2000-01-15       Impact factor: 11.361

3.  Mechanism of corepressor binding and release from nuclear hormone receptors.

Authors:  L Nagy; H Y Kao; J D Love; C Li; E Banayo; J T Gooch; V Krishna; K Chatterjee; R M Evans; J W Schwabe
Journal:  Genes Dev       Date:  1999-12-15       Impact factor: 11.361

4.  Dynamic stabilization of nuclear receptor ligand binding domains by hormone or corepressor binding.

Authors:  P Pissios; I Tzameli; P Kushner; D D Moore
Journal:  Mol Cell       Date:  2000-08       Impact factor: 17.970

5.  Recruitment of nuclear receptor corepressor and coactivator to the retinoic acid receptor by retinoid ligands. Influence of DNA-heterodimer interactions.

Authors:  E S Klein; J W Wang; B Khalifa; S A Gavigan; R A Chandraratna
Journal:  J Biol Chem       Date:  2000-06-23       Impact factor: 5.157

6.  A dominant-negative peroxisome proliferator-activated receptor gamma (PPARgamma) mutant is a constitutive repressor and inhibits PPARgamma-mediated adipogenesis.

Authors:  M Gurnell; J M Wentworth; M Agostini; M Adams; T N Collingwood; C Provenzano; P O Browne; O Rajanayagam; T P Burris; J W Schwabe; M A Lazar; V K Chatterjee
Journal:  J Biol Chem       Date:  2000-02-25       Impact factor: 5.157

7.  Ligand type-specific interactions of peroxisome proliferator-activated receptor gamma with transcriptional coactivators.

Authors:  Y Kodera; K Takeyama; A Murayama; M Suzawa; Y Masuhiro; S Kato
Journal:  J Biol Chem       Date:  2000-10-27       Impact factor: 5.157

8.  Prostacyclin-mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer.

Authors:  R A Gupta; J Tan; W F Krause; M W Geraci; T M Willson; S K Dey; R N DuBois
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

9.  The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation.

Authors:  M Ricote; A C Li; T M Willson; C J Kelly; C K Glass
Journal:  Nature       Date:  1998-01-01       Impact factor: 49.962

10.  Ligand-induced stabilization of PPARgamma monitored by NMR spectroscopy: implications for nuclear receptor activation.

Authors:  B A Johnson; E M Wilson; Y Li; D E Moller; R G Smith; G Zhou
Journal:  J Mol Biol       Date:  2000-04-28       Impact factor: 5.469

View more
  32 in total

Review 1.  Vascular effects of prostacyclin: does activation of PPARδ play a role?

Authors:  Zvonimir S Katusic; Anantha V Santhanam; Tongrong He
Journal:  Trends Pharmacol Sci       Date:  2012-06-23       Impact factor: 14.819

2.  Regulation of nuclear translocation of HDAC3 by IkappaBalpha is required for tumor necrosis factor inhibition of peroxisome proliferator-activated receptor gamma function.

Authors:  Zhanguo Gao; Qing He; Bailu Peng; Paul J Chiao; Jianping Ye
Journal:  J Biol Chem       Date:  2005-12-21       Impact factor: 5.157

3.  Ligand-activated PPARbeta efficiently represses the induction of LXR-dependent promoter activity through competition with RXR.

Authors:  Kimihiko Matsusue; Aya Miyoshi; Shigeru Yamano; Frank J Gonzalez
Journal:  Mol Cell Endocrinol       Date:  2006-08-15       Impact factor: 4.102

4.  Inhibition of HDAC3 promotes ligand-independent PPARγ activation by protein acetylation.

Authors:  Xiaoting Jiang; Xin Ye; Wei Guo; Hongyun Lu; Zhanguo Gao
Journal:  J Mol Endocrinol       Date:  2014-06-30       Impact factor: 5.098

5.  In vivo and in vitro evidence that PPARγ ligands are antagonists of leptin signaling in breast cancer.

Authors:  Stefania Catalano; Loredana Mauro; Daniela Bonofiglio; Michele Pellegrino; Hongyan Qi; Pietro Rizza; Donatella Vizza; Gianluca Bossi; Sebastiano Andò
Journal:  Am J Pathol       Date:  2011-06-23       Impact factor: 4.307

6.  USP44 Is an Integral Component of N-CoR that Contributes to Gene Repression by Deubiquitinating Histone H2B.

Authors:  Xianjiang Lan; Boyko S Atanassov; Wenqian Li; Ying Zhang; Laurence Florens; Ryan D Mohan; Paul J Galardy; Michael P Washburn; Jerry L Workman; Sharon Y R Dent
Journal:  Cell Rep       Date:  2016-11-22       Impact factor: 9.423

7.  TNIP1 is a corepressor of agonist-bound PPARs.

Authors:  Anthony M Flores; Igor Gurevich; Carmen Zhang; Vincent P Ramirez; Taylor R Devens; Brian J Aneskievich
Journal:  Arch Biochem Biophys       Date:  2011-09-22       Impact factor: 4.013

Review 8.  PPAR transcriptional activator complex polymorphisms and the promise of individualized therapy for heart failure.

Authors:  Neville F Mistry; Sharon Cresci
Journal:  Heart Fail Rev       Date:  2008-11-08       Impact factor: 4.214

Review 9.  Modulation of PPAR activity via phosphorylation.

Authors:  Katherine A Burns; John P Vanden Heuvel
Journal:  Biochim Biophys Acta       Date:  2007-05-22

10.  Ligand modulated antagonism of PPARgamma by genomic and non-genomic actions of PPARdelta.

Authors:  Mattias C U Gustafsson; Deborah Knight; Colin N A Palmer
Journal:  PLoS One       Date:  2009-09-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.